Engineering live biotherapeutic bacteria as vehicles for in situ delivery of anti-SARS-CoV-2 nanobodies
Abstract
Genetically modified probiotic bacteria were used to target viral proteins for therapeutical purposes.
Keywords:
Lactococcus lactis, protein surface display, bacterial therapy, biochemistry, COVID-19
Status
G
Department
Chemistry & Biochemistry
College
College of Arts and Sciences
Campus
Athens
Faculty Mentor
Han, Yong
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Engineering live biotherapeutic bacteria as vehicles for in situ delivery of anti-SARS-CoV-2 nanobodies
Genetically modified probiotic bacteria were used to target viral proteins for therapeutical purposes.
Social Media Link
Facebook: Carolina Portero